1mg

Molecular Formula : C3H2D5O4P • (C7H9N)

Molecular Formula : C14 D3 H14 N3 O . C4 H6 O4 . H2 O

Molecular Formula : C19 H34 N O5 P

Molecular Formula : C19H30D4NO5P

Molecular Formula : C12 H22 O

Molecular Formula : C34H40FN3O12

Molecular Formula : C29 H31 F2 N O4

Molecular Formula : C29H27D4F2NO4

Molecular Formula : C15H23NO2

Molecular Formula : C15H21D3ClNO2

Molecular Formula : C27H37NO11

Molecular Formula : C14 H21 N O2

Molecular Formula : C14H18D3NO2

Molecular Formula : C15H20D3NO2

Molecular Formula : C13 D3 H9 O3

Molecular Formula : C22 H33 N O8

Molecular Formula : C13H11D9ClNO

Molecular Formula : C10H4D6O2

Molecular Formula : C22 H32 N2 O5

Molecular Formula : C39H62D5ClO4

Molecular Formula : C22 H36 O4

Molecular Formula : C18 H25 N O

Molecular Formula : C22H28N2O4

Molecular Formula : C17H15NO4

Molecular Formula : C14 H9 Cl F3 N O4

Molecular Formula : C13H11D5N2O5S

Molecular Formula : C15 D8 H9 N3

Molecular Formula : C14 D10 H10 Cl N3 O3 . C4 H4 O4

Molecular Formula : 2 C33 H35 F N2 O5 . Ca . 2 H

Molecular Formula : C22 D5 H23 N O3 . Br

Molecular Formula : C17H14BrF4NO4S

Molecular Formula : C20 H26 N2 . C4 H4 O4

Molecular Formula : C16H12D4Cl3N

Molecular Formula : C15 2H4 H10 Cl N O2 S

Molecular Formula : C16H17D3N2O7

Molecular Formula : C32H37ClN4O6

Molecular Formula : C9 H13 N O6 S

Molecular Formula : C17H24O

Molecular Formula : C33 2H6 H30 N2 O4

Molecular Formula : C31H29BrN2O2

Molecular Formula : C24H21F2NO3

Molecular Formula : C13H11D9ClNO • HCl

Molecular Formula : C21 H25 N O4 . Cl H

Molecular Formula : C13H13D5Br2N2O

Molecular Formula : C10H18ClNOS

CCL5 or RANTES (acronym for Regulated upon Activation, Normal T cell Expressed and presumably Secreted), was initially discovered by subtractive hybridization as a transcript expressed in T cells but not B cells. Eosinophilchemotactic activities released by thrombinstimulated human platelets have also been purified and found to be identical to RANTES. Besides T cells and platelets, RANTES has been reported to be produced by renal tubular epithelium, synovial fibroblasts and selected tumor cells.

The properties of retinol binding protein is the transport carrier of vitamin A in the plasma. Human-retinol binding protein is a single-chain polypeptide with a molecular weight of approximately 21000 and one binding site for retinol and other forms of vitamin A. In addition, compounds related to retinol, such as retinal, retinoic acid, retinyl esters and geometric isomers of retinol and of retinal were evaluated for their ability to bind to this protein. In plasma, RBP4-retinol forms a complex with transthyretin (TTR), also known as thyroxine-binding protein and prealbumin. Defects in RBP4 cause retinol-binding protein deficiency, which affects night vision.

Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II), also known as Des-γ-carboxy-prothrombin (DCP), is an abnormal form of prothrombin. Normally, the prothrombin’s 10 glutamic acid residues (Glu) in the γ-carboxyglutamic acid (Gla) domain at positions 6, 7, 14, 16, 19, 20,25, 26, 29 and 32 are γ-carboxylated to Gla by vitamin-K dependent γ- glutamyl carboxylase in the liver and then secreted into plasma. In patients with hepatocellular carcinoma (HCC), γ-carboxylation of prothrombin is impaired so that PIVKA-II is formed instead of prothrombin. PIVKA-II is considered as is an efficient biomarker specific for HCC.